Your browser doesn't support javascript.
loading
Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting.
Ping, Yang; Hongmei, Jing; Bellmann, Christian; Inês, Mónica; Macmillan, Tom; Webb, Neil; Aram, Jalal A; Penack, Olaf.
Affiliation
  • Ping Y; Peking University Third Hospital, Beijing, People's Republic of China.
  • Hongmei J; Peking University Third Hospital, Beijing, People's Republic of China.
  • Bellmann C; Pfizer Pharma GmbH, Berlin, Germany.
  • Inês M; Patient Health Impact, Pfizer Inc, Porto Salvo, Portugal.
  • Macmillan T; Source Health Economics, London, UK.
  • Webb N; Source Health Economics, Oxford, UK.
  • Aram JA; Pfizer Inc, Groton, CT, USA.
  • Penack O; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Hematology ; 27(1): 723-732, 2022 Dec.
Article in En | MEDLINE | ID: mdl-35688453

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Invasive Fungal Infections / Antifungal Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Qualitative_research / Systematic_reviews Limits: Adult / Humans Language: En Journal: Hematology Journal subject: HEMATOLOGIA Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Invasive Fungal Infections / Antifungal Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Qualitative_research / Systematic_reviews Limits: Adult / Humans Language: En Journal: Hematology Journal subject: HEMATOLOGIA Year: 2022 Type: Article